Autoantibody mediated pathogenesis in chronic rhinosinusitis with nasal polyps: mechanisms and consequences
自身抗体介导的慢性鼻窦炎伴鼻息肉的发病机制:机制和后果
基本信息
- 批准号:10388102
- 负责人:
- 金额:$ 39.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-25 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptive Immune SystemAdrenal Cortex HormonesAffinityAirway DiseaseAntibodiesAntigensAutoantibodiesAutoantigensAutoimmunityB-Cell ActivationB-LymphocytesBasement membraneBindingBiological MarkersCase-Control StudiesCellsChronicClinicalCollaborationsComplementComplement 2Complement ActivationComplement component C1rDNADepositionDiagnostic testsDiseaseDropoutEnvironmentEpithelialFrequenciesFutureGoalsHealthHeavy-Chain ImmunoglobulinsHumanIgG autoantibodiesImmuneImmunoglobulin-Secreting CellsImpairmentIn VitroInflammationInflammatoryInvestigationLaboratoriesMediatingMedicalMentored Patient-Oriented Research Career Development AwardModelingMolecular TargetMonoclonal AntibodiesMucosal ImmunityMucous MembraneMusNasal PolypsNuclearNuclear AntigensOperative Surgical ProceduresPathogenesisPathogenicityPatientsPhenotypePlasmablastPlayPositioning AttributePostoperative PeriodPrincipal InvestigatorPropertyProteinsQuality of lifeRecurrenceResearchRoleSamplingScientistSinusStructure of mucous membrane of noseSurfaceSurgeonSurgical ManagementSurvival AnalysisSymptomsTestingTimeTissuesTonsilTranslational ResearchWorkantimicrobialautoreactive B cellautoreactivitybasechronic rhinosinusitisclinical phenotypecohortcomplement C4dcross reactivityds-DNAenzyme linked immunospot assayeosinophilic inflammationexperienceexperimental studyhuman diseaseimmunoglobulin structureimmunopathologyimprovedinterestlymphoid organmatrigelmicrobialmicroorganism antigenmouse modelmucosal sitenatural antibodiesnovelnovel diagnosticsnovel markerpreventprognosticprognostic valueprospectivereceptorreduce symptomsresponsetranscriptome sequencingtranslational impact
项目摘要
Project Summary
B-cells and antibodies are a critical interface between the innate and adaptive immune systems since they
have both natural and acquired recognition of microbial antigens. However, the antibodies that naturally bind
microbial antigens frequently also react with self-antigens and, in health, these autoreactive B-cells have to be
stringently regulated to prevent autoimmunity. Recent evidence from our laboratory has previously
demonstrated that B-cells, plasmablasts and self-reactive autoantibodies against DNA and the basement
membrane are strikingly elevated in nasal polyp tissue especially in patients with severe disease. Furthermore,
we find that highly specific markers for antibody-mediated complement activation like C4d and C1rs-inh are
found at high levels within nasal polyp tissue suggesting these antibodies are activating potent pro-
inflammatory immune cascades. Our central hypotheses for the proposed work are: 1) that the these
autoantibodies are cross-reactive with natural antibodies that bind microbial antigens, 2) that the levels of
autoreactive antibodies may predict nasal polyp recurrence and 3) that the autoreactive B-cells in nasal polyps
may represent a pathogenic manifestation of a subtype of B-cells called B-1 cells that have been well
characterized in mice but remain enigmatic in humans. In the highly translational research proposed, we will
leverage the Principal Investigator’s expertise as a surgeon-scientist whose clinical interests focus on CRS
patients with his research interests in mucosal immunity. Specific aims in the experiments will: (1) identify the
specific tissue antigens that are recognized by nasal polyp derived antibodies and evaluate their potential to
cross-react with microbial proteins and activate complement; (2) comprehensively analyze samples collected
from a prospective observational trial of nasal polyp recurrence after sinus surgery for autoantibodies and
complement. Survival analysis will then be used to evaluate the biomarkers that provide significant prognostic
information; and (3) isolate the cells producing autoantibodies to identify lineage markers, conduct analysis of
antibody structural diversity and generate monoclonal autoantibodies from these cells for future studies. If
successful, these studies will firmly establish a novel pathogenic mechanism in a debilitating upper airway
disease, validate novel biomarkers of prognostic value, and discover fundamental features of human mucosal
B-cells.
项目概要
B 细胞和抗体是先天性免疫系统和适应性免疫系统之间的关键接口,因为它们
具有对微生物抗原的天然识别和后天识别,但是,天然结合的抗体。
微生物抗原也经常与自身抗原发生反应,在健康情况下,这些自身反应性 B 细胞必须
最近我们实验室的证据以前
证明 B 细胞、浆母细胞和针对 DNA 和基底的自身反应性自身抗体
鼻息肉组织中的膜显着升高,尤其是在患有严重疾病的患者中。
我们发现抗体介导的补体激活的高度特异性标记物,如 C4d 和 C1rs-inh
在鼻息肉组织中发现高水平,表明这些抗体正在激活有效的亲
我们对拟议工作的中心假设是:1)这些
自身抗体与结合微生物抗原的天然抗体发生交叉反应,2)
自身反应性抗体可以预测鼻息肉复发,3) 鼻息肉中的自身反应性 B 细胞
可能代表一种称为 B-1 细胞的 B 细胞亚型的致病表现,这种细胞已被很好地
在小鼠中具有特征,但在人类中仍然是个谜。在提出的高度转化研究中,我们将
利用首席研究员作为临床兴趣集中于 CRS 的外科医生科学家的专业知识
实验的具体目标是:(1)确定粘膜免疫的研究兴趣。
鼻息肉衍生抗体识别的特定组织抗原并评估其潜力
(2)对采集的样品进行综合分析
来自一项针对自身抗体鼻窦手术后鼻息肉复发的前瞻性观察试验
然后,生存分析将用于评估提供重要预后的生物标志物。
信息;和(3)分离产生自身抗体的细胞以鉴定谱系标记,并进行分析
抗体结构多样性并从这些细胞中产生单克隆自身抗体用于未来的研究。
如果成功,这些研究将在衰弱的上呼吸道中牢固地建立一种新的致病机制
疾病,验证具有预后价值的新型生物标志物,并发现人类粘膜的基本特征
B 细胞。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Radiographic disease severity in chronic rhinosinusitis patients and health care utilization.
- DOI:10.1002/lio2.663
- 发表时间:2021-10
- 期刊:
- 影响因子:1.9
- 作者:Mehta MP;Hur K;Price CPE;Shintani-Smith S;Welch KC;Conley DB;Kern RC;Tan BK
- 通讯作者:Tan BK
Chronic rhinosinusitis: Future treatments and unmet needs.
- DOI:10.1016/j.jaci.2022.05.016
- 发表时间:2022-08
- 期刊:
- 影响因子:14.2
- 作者:Giri, Sneha;Schneider, Alexander L.;Tan, Bruce K.
- 通讯作者:Tan, Bruce K.
Responsiveness and convergent validity of the chronic rhinosinusitis patient-reported outcome (CRS-PRO) measure in CRS patients undergoing endoscopic sinus surgery.
- DOI:10.1002/alr.22782
- 发表时间:2021-09
- 期刊:
- 影响因子:6.4
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce K Tan其他文献
Bruce K Tan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce K Tan', 18)}}的其他基金
Type-2 inflammation mediates olfactory loss in Chronic Rhinosinusitis: mechanisms and therapeutic opportunities
2 型炎症介导慢性鼻窦炎的嗅觉丧失:机制和治疗机会
- 批准号:
10219804 - 财政年份:2018
- 资助金额:
$ 39.5万 - 项目类别:
Autoantibody mediated pathogenesis in chronic rhinosinusitis with nasal polyps: mechanisms and consequences
自身抗体介导的慢性鼻窦炎伴鼻息肉的发病机制:机制和后果
- 批准号:
9903228 - 财政年份:2018
- 资助金额:
$ 39.5万 - 项目类别:
Type-2 inflammation mediates olfactory loss in Chronic Rhinosinusitis: mechanisms and therapeutic opportunities
2 型炎症介导慢性鼻窦炎的嗅觉丧失:机制和治疗机会
- 批准号:
10417217 - 财政年份:2018
- 资助金额:
$ 39.5万 - 项目类别:
Role for B-cell mediated olfactory loss in Chronic Sinusitis with Nasal Polyps
B 细胞介导的嗅觉丧失在慢性鼻窦炎伴鼻息肉中的作用
- 批准号:
8399713 - 财政年份:2011
- 资助金额:
$ 39.5万 - 项目类别:
Role for B-cell mediated olfactory loss in Chronic Sinusitis with Nasal Polyps
B 细胞介导的嗅觉丧失在慢性鼻窦炎伴鼻息肉中的作用
- 批准号:
8225845 - 财政年份:2011
- 资助金额:
$ 39.5万 - 项目类别:
Role for B-cell mediated olfactory loss in Chronic Sinusitis with Nasal Polyps
B 细胞介导的嗅觉丧失在慢性鼻窦炎伴鼻息肉中的作用
- 批准号:
8586309 - 财政年份:2011
- 资助金额:
$ 39.5万 - 项目类别:
相似国自然基金
下丘脑室旁核促肾上腺皮质激素释放激素神经元调控奖赏偏好行为的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
孕期促肾上腺皮质激素释放激素(CRH)通过引起DNA甲基化发生程序化稳定改变长期影响婴幼儿神经行为发育
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:
INSM1在静默性促肾上腺皮质激素细胞腺瘤发生发展中的调控机制及潜在靶向治疗研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
促肾上腺皮质激素释放因子通过CRFR1-cAMP-SphK1通路介导肥大细胞脱颗粒参与胰腺癌痛外周敏化
- 批准号:82171232
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
催产素参与双相障碍发病机制的研究:聚焦于促肾上腺皮质激素释放激素与催产素之间的平衡紊乱
- 批准号:81971268
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Decoding the functional pleiotropy of IL-20Rβ ligands in inflammation and tumorigenesis
解码 IL-20Rβ 配体在炎症和肿瘤发生中的功能多效性
- 批准号:
10350447 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
- 批准号:
10659658 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
Selective Inhibitors of T Cell Activation Target Exportin-1 at Cys528 to Suppress Pathological T Cell Activation
T 细胞激活的选择性抑制剂 Cys528 靶点 Exportin-1 抑制病理性 T 细胞激活
- 批准号:
10659905 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection after Lung Transplantation
Siltuximab 治疗肺移植后抗体介导的排斥反应的 1 期临床试验
- 批准号:
10714920 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
MV2C2 antibody as a new therapeutic for Myasthenia Gravis
MV2C2 抗体作为重症肌无力的新疗法
- 批准号:
10546538 - 财政年份:2022
- 资助金额:
$ 39.5万 - 项目类别: